News
Regeneron Pharmaceuticals logged a 0.4% change during today's morning session, and is now trading at a price of $571.03 per share. The S&P 500 index moved -2.0%. REGN's trading volume is 167,455 ...
“At its heart, the logo captures the dynamic intersection between humanity and technology – two forces that shape our world and inspire our work. The design embodies the fluidity and warmth of ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Regeneron Pharmaceuticals' first-quarter net income rose but revenue fell due to inventory issues and generic competition for its best-selling biopharmaceuticals, and the company trimmed its ...
(Reuters) -Regeneron's first-quarter results missed Wall Street estimates on Tuesday due to stiff competition for its blockbuster drug Eylea, further stoking investor worries as U.S. regulators denied ...
TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported first-quarter profit of $808.7 million. The Tarrytown, New York-based company said it ...
On Tuesday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted earnings per share of $8.22, down 14% year-over-year, missing the consensus of $8.82. The company reported ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the first quarter of 2025 and provided a business update.
But did you know how much thought and effort is put into making a single logo design? More than meets the eye, a logo is beautiful and represents the brand’s identity. It should tell everything about ...
Mercedes wants to make life easier for drivers, and that’s the mentality behind the yoke design. It saves space by making the steering wheel smaller, aiding driver ingress and egress.
The design of Escambia County’s new, $1.6 million architectural arch proposed to replace the toll booths at the entrance to Pensacola Beach was mistakenly copied from the logo used by Innisfree ...
Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results